共 50 条
- [44] MATERNAL FACTORS ASSOCIATED WITH PERINATAL HIV-1 TRANSMISSION - THE FRENCH COHORT STUDY - 7 YEARS OF FOLLOW-UP OBSERVATION [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (02): : 188 - 194
- [45] Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (19): : 1504 - 1506
- [46] Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05): : 463 - 467
- [47] Reducing the risk of perinatal HIV-1 transmission with zidovudine: Results and implications of AIDS Clinical Trials Group protocol 076 [J]. ACTA PAEDIATRICA, 1997, 86 : 89 - 96
- [49] Adequacy of prenatal care and prescription of zidovudine to prevent perinatal HIV transmission [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (03): : 223 - 227